Leadership

Our leaders have been working in healthcare for more than a combined 100 years—time that has taught them the nuances of the healthcare industry and cancer treatment on both a professional and personal level.

Cancer Expert Now, Born Out of Experience on YouTube

Leadership

Our leaders have been working in healthcare for more than a combined 100 years—time that has taught them the nuances of the healthcare industry and cancer treatment on both a professional and personal level.

Jeff W. Meehan

Co-Founder and CEO

For Jeff, Cancer Expert Now is personal. He wants to take his experience and give you the same access to an expert he was luckily enough to have in his time of need…

Read More Jeff W. Meehan

Sanjiv Agarwala, MD

Co-Founder, President,
Chief Medical Officer

Sanjiv Agarwala, MD, served as Chief of Medical Oncology & Hematology at St. Luke’s Cancer Center, located in Bethlehem, Pennsylvania. Additionally, he was…

Read More Sanjiv Agarwala, MD

Charles M. Balch,
MD, PhD (hc)

President, Cancer Expert
Now International

Dr. Charles M. Balch has led a distinguished career as a clinical and academic surgical oncologist for the past 39 years, as a leading…

Read More Charles M. Balch,
MD, PhD (hc)

Richard Goldstein, MD

Chief Technology Officer

Combining over 20 years of clinical practice experience and development of electronic health record software, Rich has been able to find the nexus between effective clinical…

Read More Richard Goldstein, MD

Bruce Johnson

EVP,
Chief Commercial Officer

Bruce Johnson is the Executive Vice President and Chief Commercial Officer of CEN. He has more than 25 years of oncology therapeutic area and life sciences…

Read More Bruce Johnson

Jagruti Oza

Chief Data Officer

Jagruti is passionate about improving healthcare in the US and the world through the innovative use of technology, information and analytics combined with a compassionate…

Read More Jagruti Oza

Donald L. Trump,
MD, FACP, FASCO

Director, Institutional Relationships

Donald L. Trump, MD, FACP, has been a leader of comprehensive cancer center scientific, clinical and education programs for more than 2 decades. He has served as…

Read More Donald L. Trump,
MD, FACP, FASCO

Jeff W. Meehan

Co-Founder and CEO

For Jeff, Cancer Expert Now is personal. He wants to take his experience and give you the same access to an expert he was luckily enough to have in his time of need.

Jeff has been actively involved in cancer research, education and healthcare IT for over 25 years. He has started and sold numerous companies including Educational Concept in Medicine LLC, Broadleaf Creative Group LLC, and Strategic Edge Communications, Inc. As part of the Strategic Edge acquisition, he became the Chief Commercial Officer of MDOL, Inc. where he honed his skills in patient privacy and monetizing and leveraging “big data.” Jeff was instrumental in the November 2014 acquisition of MDOL, Inc. to the venture backed Ability Network, Inc. Jeff was recently honored by PM360, a well-respected health care publication with an entrepreneur award. He takes pride in mentoring young entrepreneurs across the tristate area.

Sanjiv Agarwala, MD

Co-Founder, President, Chief Medical Officer

Sanjiv Agarwala, MD – Co-founder, President, and Chief Medical Officer of Cancer Expert Now. He is a world-renowned medical oncologist who has been actively involved in driving scientific innovation in melanoma and in non-melanoma skin cancer. He chairs numerous conferences, is highly respected by his peers and served most recently as the Chief of Oncology and Hematology at St. Luke’s Cancer Center in Bethlehem, PA and previously as Associate Chief of Oncology at the University of Pittsburgh Medical Center.

Charles M. Balch, MD, PhD (hc)

President, Cancer Expert Now International

Dr. Charles M. Balch has led a distinguished career as a clinical and academic surgical oncologist for the past 39 years, as a leading authority in both melanoma and breast cancer. He is author of over 730 publications and has lectured in over 38 different countries in the world and most of the major academic centers in the United States. Dr. Balch is the founding Editor-in-Chief of the Annals of Surgical Oncology, which is recognized as the leading journal in the world in its field.

In past years, Dr. Balch has served as Executive Vice President and CEO of the American Society of Clinical Oncology (2000-2005), and as President and CEO of the City of Hope National Medical Center (1996-1999). At the University of Texas M.D. Anderson Cancer Center, from 1985-1996, Dr. Balch served as Executive Vice President for Health Affairs, Vice President of Hospital and Clinics, and Head of the Division of Surgery, among other positions. Dr. Balch’s leadership roles have involved the Society of Surgical Oncology (as President in 1992), the American Board of Surgery (Board of Directors), the Association of Academic Surgeons (President) and the Commission on Cancer (Chair, Board of Directors) and the American Joint Committee on Cancer (Executive Committee).

Richard Goldstein, MD

Chief Technology Officer

Combining over 20 years of clinical practice experience and development of electronic health record software, Rich has been able to find the nexus between effective clinical workflows and healthcare information technology. As an innovator in clinical record systems in an outpatient setting, he designed and developed EMR/EHR system resulting in improved clinician workflow and therefore greater adoption of EMR systems, increased bottom line of practices, and enhanced communication between clinicians-and-staff, and clinicians-and-patients.

Having navigated two EMR/EHR products to meaningful use certification (2011 edition and 2014 edition). He is uniquely aware of the impact of regulatory mandates in HIT on clinical practice, and can find ways to incorporate these requirements into clinically effective workflows which improve the user experience for physicians, staff and patients. He is also an expert in HIPAA privacy regulations, data integrity and security and in optimizing the user experience.

Bruce Johnson

EVP, Chief Commercial Officer

Bruce Johnson is the Executive Vice President and Chief Commercial Officer of CEN.  He has more than 25 years of oncology therapeutic area and life sciences industry experience working with pharmaceutical and academic institutions. He has deep expertise in the areas of strategy development and strategic brand planning, product launch, marketing, business development, new product evaluation and post-merger integration. Bruce is a published author and has been directly involved in the successful launch of several leading oncology and hematology brands, including: Gleevec®/Glivec®, Tasigna®, Aredia®, Zometa®, Exjade®, Promacta®/ Revolade®, Afinitor®, Jakavi®, Zykadia®, Sandostatin®, Sandostatin LAR® Depot, Rydapt®, Venclexta® and Imbruvica®.

Prior to joining Pharma Health Labs and Cancer Expert Now, Bruce was Vice President, Oncology Global Commercial Development at AbbVie. Bruce was also Vice President and Global Franchise Head, Malignant Hematology at Novartis Pharmaceuticals Corporation and received his oncology training at MSKCC as a Clinical Research and Data Coordinator for the GI Solid Tumor Service.

Industry Specialization: Healthcare and Life Sciences, Pharmaceuticals, Diagnostics

Jagruti Oza

Chief Operating Officer

Jagruti is passionate about improving healthcare in the US and the world through the innovative use of technology, information and analytics combined with a compassionate human touch. She brings more than 20 years of senior executive experience in general management, operations, strategy, partnerships and acquisitions. In her most recent role as Executive Vice President at Wolters Kluwer Health, a global information and publishing company, she focused on healthcare analytics and business development in the US, India and China. Previously, Ms. Oza was Executive Vice President & General Manager at Solucient, LLC (now Truven Analytics/IBM Watson) and Management Consultant at Bain & Company. She is a former Board member of Oxfam America and currently Chairman of The Board at The Summit Area YMCA. She received her Bachelors Degree in Chemical Engineering from University College London and an MBA at Harvard Business School.

Donald L. Trump, MD, FACP, FASCO

Director, Institutional Relationships

Donald L. Trump, MD, FACP, has been a leader of comprehensive cancer center scientific, clinical and education programs for more than 2 decades. He has served as director of experimental therapeutics at Duke Comprehensive Cancer Center, deputy director for clinical investigations at the University of Pittsburgh Cancer Institute, and he was the president and CEO of Roswell Park Cancer Institute (RPCI) from 2007 to 2014, in which he led the successful competitive renewal of the RPCI National Cancer Institute Comprehensive Cancer Center Support Grant (CCSG) twice. From 2002 to 2007, he was co-PI of the Roswell Park CCSG, associate institute director, and senior vice president for clinical investigation. He has been co-PI or PI on numerous peer-reviewed National Institutes of Health, Department of Defense, and American Cancer Society grants.

In 2015, Dr. Trump moved to Northern Virginia as founding director of the newly established Inova Schar Cancer Institute (ISCI), a part of the Inova Health System, and was appointed professor of medicine at the University of Virginia. In early 2019, Dr. Trump retired from his ISCI leadership position. Since retirement Dr. Trump continues to act as a senior advisor to several cancer centers and drug development companies. He and his colleague, Eric Rosenthal have written a book, Centers of the Cancer Universe: 50 Years of Progress Against Cancer which will be published by Rowan and Littlefield in October, 2021.